Shin Etsu Chemical (TSE:4063) Stock Faces Q2 Earnings Valuation Check

Shin-Etsu Chemical just posted Q2 2027 results and the stock closed at ¥6,010, only a modest gain over the past month despite a firmer earnings picture. Basic earnings per share printed at ¥85.45 on total revenue of ¥758,260m, feeding into trailing 12 month earnings of ¥271.41 per share.

That is the strongest positive thread in the story, yet market reaction looks restrained for a stock sitting on a 21.7x P/E and facing questions about a slightly softer net margin and an uneven dividend record. Sentiment appears cautious. The core business looks more confident than the price move suggests.

Like the earnings profile at Shin-Etsu Chemical but uneasy about the rich 21.7x P/E and patchy dividend history? You can filter for a tighter balance of quality and valuation using our 15 high quality undervalued stocks.

Q2 2027 Earnings Summary

• Total Revenue (Q2 2027 vs. Q2 2026): ¥758,260m vs. ¥655,973m (up about 15.6%)
• Net Income (Excl. Extra Items, Q2 2027 vs. Q2 2026): ¥156,110m vs. ¥131,416m (up about 18.8%)
• Basic EPS (Q2 2027 vs. Q2 2026): ¥85.45 vs. ¥70.16 (up about 21.8%)
• Trailing 12-Month Net Income (Excl. Extra Items, Q2 2027 vs. Q2 2026): ¥503,554m vs. ¥497,748m (up about 1.2%)

Fast-rising earnings meet a premium multiple and DCF upside. Ask Charlie what makes Shin-Etsu look undervalued despite a high P/E.

Shin-Etsu bullish story leans on resilient earnings

For anyone leaning positive on Shin-Etsu Chemical, the earnings line gives some backing. Revenue of ¥758,260m and net income of ¥156,110m both run ahead of the prior Q2, and basic EPS rose from ¥70.16 to ¥85.45. Trailing 12 month profit is only slightly above last year, which points to a flatter longer stretch, yet the latest quarter tilts the trend in a healthier direction. For a materials and electronics supplier tied to semiconductors and specialty chemicals, that mix of top line progress and firmer profitability supports the quality angle.

Bear case anchored in slower profit momentum and risks

The cautious view still has some footing. Trailing 12 month net income is only modestly higher at ¥503,554m versus ¥497,748m, so earnings momentum over the full year looks muted. That limits evidence of a strong upcycle in Shin-Etsu Chemical’s broader portfolio. External pressure also matters. Recent Chinese anti dumping deposits on dichlorosilane add a fresh policy risk around chip materials. Quarterly EPS and revenue are moving in the right direction, yet the longer stretch plus trade friction keeps the risk side of the story alive.

Are investors right to read Shin-Etsu Chemical’s latest quarter as a quiet reset rather than a powerful inflection in earnings quality, or do analysts see it differently? Check the consensus price target analysis for Shin-Etsu Chemical.

Hunt For Quiet Mispricings Now

Shin-Etsu Chemical just showed how earnings strength and share price can tell slightly different stories. The real opportunity is spotting stocks that could be undervalued before the gap closes.

• Company 1 - 35% below our estimate - focuses on long term infrastructure projects where clients increasingly demand integrated construction, seismic reinforcement, and ongoing facility management under one roof.
• Company 2 - 42% below our estimate - expands a multi service auto platform that captures customers from first purchase through inspections, repairs, coatings, and insurance renewals.
• Company 3 - 30% below our estimate - supplies critical photomasks as chipmakers shift production to finer geometries and need more precise, customized patterning tools.

Those are three of them. See all 15 potentially undervalued companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com